Rhythio Medical Receives FDA Breakthrough Device Designation for Injectable Electrode Technology Enabling Painless, Imperceptible Defibrillation
Rhythio Medical, a medical device company pioneering injectable bioelectronic therapies, today announced that its Injectable Electrode System has received Breakthrough Device Designation from the U.S. Food and Drug Administration...
